Skip to content

Observation of the selective inhibition of BV flora in patients with bacterial vaginosis (BV) by the Charming Gel

Observation of the selective inhibition of BV flora in patients with bacterial vaginosis (BV) by the Charming Gel

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037793
Enrollment
Unknown
Registered
2020-09-02
Start date
2020-08-20
Completion date
Unknown
Last updated
2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bacterial vaginosis (BV)

Interventions

Case series:Charming Gel

Sponsors

First Affiliated Hospital of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18-45 years old female with sexual history; (2) Patients with no or symptomatic BV; (3) vaginal microecology examination: pH>4.5, Nugent score >=7, White blood cell count:<10/ HP; (4) No history of systemic antibiotic use in the past week; (5) Asexual life history within the last three days, no bath, vaginal flushing or drug discharge.

Exclusion criteria

Exclusion criteria: (1) Pregnant and lactating women; (2) White blood cell count of vaginal secretions:>=10/ HP; (3) Other diseases of vagina or vulva; (4) Medical history of diabetes, cardiovascular and cerebrovascular diseases, liver and kidney diseases, hematopoietic system and other diseases (ask for previous medical history); (5) Approaching menstrual period: the date of the last menstrual period is speculated to be 12 days from the next menstrual period; (6) A history of drug allergy.

Design outcomes

Primary

MeasureTime frame
Nugent score;pH;White blood cell count;

Countries

China

Contacts

Public ContactAn Ruifang

The First Affiliated Hospital of Xi'an Jiaotong University

anruifang@163.com+86 18991232090

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026